Clinical trial
A Comparison of Standard Vs Renal Dosing of Piperacillin/Tazobactam in Acute Renal Failure and Septic Shock
NCT00816790 is registered in ClinicalTrials.gov with Fraser Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Comparison of Standard Vs Renal Dosing of Piperacillin/Tazobactam in Acute Renal Failure and Septic Shock
- Lead sponsor
- Fraser Health
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- January 31, 2009
- Completion date
- June 30, 2011
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute renal failure, septic shock